Poly ICLC is an immunostimulant. It is polyinosinic-polycytidylic acid (poly I:C) mixed with the stabilizers carboxymethylcellulose and polylysine. It...
2 KB (122 words) - 19:58, 3 December 2023
Polyinosinic:polycytidylic acid (redirect from Poly I:C)
physicochemical properties of poly I:C has led to generation of derivatives that have increased stability in body fluids (such as polyICLC), or reduced toxicity...
5 KB (396 words) - 08:34, 8 March 2024
combined with the adjuvant Poly-ICLC. A Phase 1b study has been completed assessing the safety and tolerability of HspE7 with Poly-ICLC in four cohorts totaling...
9 KB (1,008 words) - 10:01, 27 December 2023
in combination with the Toll-like receptor 3 (TLR3) agonist adjuvant Poly-ICLC for multiple indications, including Cervical Intraepithelial Neoplasia...
9 KB (803 words) - 06:05, 3 April 2023
L03AX03 BCG vaccine L03AX04 Pegademase L03AX05 Pidotimod L03AX07 Poly I:C L03AX08 Poly ICLC L03AX09 Thymopentin L03AX10 Immunocyanin L03AX11 Tasonermin L03AX12...
2 KB (353 words) - 05:13, 18 December 2023
pneumonectomy – PNU 166148 – PNU-93914 – polifeprosan 20 carmustine implant – poly-ICLC – polyglutamate camptothecin – polyglutamate paclitaxel – polymerase chain...
69 KB (5,119 words) - 11:20, 3 June 2024
vaccine (ISV), combining Flt3L, local radiotherapy, and a TLR3 agonist (poly-ICLC), could recruit, antigen-load and activate intratumoral cross-presenting...
7 KB (724 words) - 07:25, 22 October 2022